Teva Pharmaceuticals and Alvotech have announced that the US Food and Drug Administration (FDA) has approved the Selarsdi ...

The subcutaneous formulation of daratumumab makes treatment a faster and more tolerable process for patients with multiple ...

This wearable delivery system enables large-volume, high-viscosity subcutaneous drug administration in either clinical settings or home self-administration.” Cincinnati-based Enable Injections is a ...

The National Association of Experts in the Field of Primary Immunodeficiencies shared the results of a study evaluating the effectiveness of subcutaneous immunoglobulin administration in patients with ...

The participants were randomly assigned to receive either a placebo or one or two subcutaneous injections of lepodisiran. The study’s participants were randomly assigned to try a placebo or one ...